Dasotraline Hydrochloride

N/A

Report date: 2024/06/24 20:00:45
NME

Base Information

Drug NameDasotraline Hydrochloride
Drug Alias Name达索曲林DasotralinumDasotralineDasotralinaDSP-225289 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsDopamine transporter antagonistsNorepinephrine transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorBinge-Eating Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponSumitomo Pharma America IncSunovion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorBinge-Eating Disorder

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG